hydrazinocurcumin has been researched along with Stomach-Neoplasms* in 1 studies
1 other study(ies) available for hydrazinocurcumin and Stomach-Neoplasms
| Article | Year |
|---|---|
Inhibition of histone/lysine acetyltransferase activity kills CoCl
Hypoxia enhances immortality and metastatic properties of solid tumors. Deregulation of histone acetylation has been associated with several metastatic cancers but its effect on hypoxic responses of cancer cells is not known. This study aimed at understanding the effectiveness of the hydrazinocurcumin, CTK7A, an inhibitor of p300 lysine/histone acetyltransferase (KAT/HAT) activity, in inducing apoptosis of gastric cancer cells (GCCs) exposed to cobalt chloride (CoCl Topics: Acetylation; Antineoplastic Agents; Apoptosis; Cell Line, Transformed; Cell Line, Tumor; Cobalt; Curcumin; E1A-Associated p300 Protein; Enzyme Inhibitors; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Hydrogen Peroxide; MAP Kinase Signaling System; Neoplasm Invasiveness; Oxidative Stress; Reactive Oxygen Species; Solubility; Stomach Neoplasms; Tumor Hypoxia | 2017 |